Abbott Laboratories vs. Arcutis Biotherapeutics, Inc. Common Stock
ABT
Abbott Laboratories
$109.29 -1.06%
VS ARQTArcutis Biotherapeutics, Inc. Common Stock
$32.07 +0.31%
Abbott Laboratories and Arcutis Biotherapeutics, Inc. Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| ABT | ARQT | |
|---|---|---|
| Market Cap | $189.28 billion | $4.03 billion |
ABT leads on 1 of 1 size & scale factors.
Dividend
| ABT | ARQT | |
|---|---|---|
| Dividend Yield | 2.31% | — |
ABT and ARQT split the dividend factors evenly.
Risk & Sentiment
| ABT | ARQT | |
|---|---|---|
| Short Interest | 0.57% | 0.19% |
ARQT leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABT overview, ABT financials, ARQT overview, ARQT financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.